HEALTH-ASTRAZENECA-EXANTA (URGENT)
Thu Sep 9, 2004 08:16 AM ET
LONDON, Sept 9 (Reuters) - Officials at the U.S. Food and Drug Administration have questioned both the efficacy and safety of AstraZeneca Plc's (AZN.L: Quote, Profile, Research) new anti-stroke pill Exanta, according to documents...